|
|
| | | U.S. Protests |
Virginia prosecutors said a man facing charges for driving his pickup truck into racial equality protesters is a local leader of the Ku Klux Klan. Harry H. Rogers, 36, was charged with assault and battery, malicious wounding and felony vandalism, the Henrico County police department said in statement.
Bail for the white former Minneapolis police officer charged with murdering African American George Floyd, whose death ignited two weeks of protests, was raised by $250,000 to $1.25 million at a hearing. Former officer Derek Chauvin, 44, has been charged with second- and third-degree murder and manslaughter in Floyd’s May 25 death in Minneapolis by kneeling on his neck for nearly nine minutes. | |
| What you need to know about the coronavirus today |
Could the virus have spread in August?
The coronavirus might have been spreading in China as early as August last year, according to Harvard Medical School research based on satellite images of hospital travel patterns and search engine data.
The research showed a steep increase in hospital car park occupancy at that time and a unique increase in searches for diarrhea. But a Chinese Foreign Ministry spokeswoman dismissed the findings. “I think it is ridiculous, incredibly ridiculous, to come up with this conclusion based on superficial observations such as traffic volume,” she said.
Not the time to take foot off pedal
More than 136,000 new coronavirus cases were reported worldwide on Sunday, the most in a single day so far, World Health Organization (WHO) Director General Tedros Adhanom Ghebreyesus told an online meeting. “More than six months into the pandemic, this is not the time for any country to take its foot off the pedal,” he said.
WHO’s top emergencies expert, Dr. Mike Ryan, said infections in central American countries including Guatemala were still on the rise, and that they were “complex” epidemics.
| | | |
| |
Treatment hopes
While some potential vaccines have emerged in the global race to find a way to stop the spread of COVID-19, many scientists and researchers believe antibody based therapies hold great promise for treating people already infected with the disease.
AstraZeneca said it expects to move two antibody therapies it has licensed from U.S. researchers into clinical studies in the next two months as the drugmaker ramps up efforts to help combat the health crisis.
A study published in medical journal Nature meanwhile showed Gilead Sciences’s antiviral drug, remdesivir, prevented lung disease in monkeys infected with the coronavirus. Remdesivir has been cleared for emergency use in severely-ill patients in the United States, India and South Korea.
South Korea’s Daewoong Pharmaceutical said its anti-parasitic drug niclosamide had eliminated the novel coronavirus from animals’ lungs during testing.
The drug completely cleared up the disease in ferrets’ lung tissues and inhibited inflammation. The company plans to start human clinical trials in July.
This round’s on us, says Malta
Residents of Malta will be given $112 vouchers by the government to spend in bars, hotels and restaurants in an effort to revitalize the tourist industry.
Tourism accounts for a quarter of the Mediterranean island’s GDP but it has been at a standstill since mid-March when flights were stopped during the coronavirus emergency.
Flights to a small number of countries will resume on July 1 but they exclude big tourism source markets Britain and Italy. | |
| |
| |
Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources. Here’s a look at our coverage.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | |
|
| |
|
|
| | Life under lockdown |
| |
British breeders of puppies have seen a huge surge in demand for dogs during the lockdown and now fear that many families will give them up once they realise the scale of the responsibility ahead. Millions of Britons have spent almost three months largely confined to their homes to counter the spread of COVID-19, a time when the Kennel Club group has seen a 180% rise on last year in inquiries from people wanting to buy dogs. Many breeders are worried that some Britons may be wanting to buy a puppy to keep the children entertained. | |
| COVID Science |
| |
Lockdowns may have averted millions of deaths
Wide-scale lockdowns, including business and school closures, to reduce COVID-19 transmission in Europe may have averted more than three million deaths on that continent, researchers said on Monday in the journal Nature. Using computer models to estimate the lockdown impact in 11 nations, British scientists said the draconian steps, introduced mostly in March, had "a substantial effect."
A separate study by U.S. scientists, published alongside the European one, estimated that lockdowns in China, South Korea, Italy, Iran, France and the United States prevented or delayed around 530 million COVID-19 cases. The authors of the second paper say that while lockdowns "impose large and visible costs on society," the data show "consistent evidence that the policy packages now deployed are achieving large, beneficial, and measurable health outcomes." | |
|
| |
|
|
| | Top Stories on Reuters TV |
|
| |
|
|
|